Does this mean a mass spectrum proves the blend is correct?

It proves four species of the expected masses are present. It does not establish their proportions, their purity, or that the material is what the label says in every respect - a correct mass is consistent with the right compound and does not by itself exclude an isomer.

Why can leucine and isoleucine not be told apart by mass?

They have identical elemental composition and therefore identical mass. Distinguishing them requires fragmentation patterns or chromatographic behaviour, which is a standard problem in peptide analysis and simply does not arise between these four components.

Is the copper isotope pattern hard to see?

No - it is one of the more recognisable signatures in small-molecule mass spectrometry, because the two stable isotopes are separated by two mass units in a consistent ratio. Its absence where copper is claimed is straightforward to notice.

Does easy identification mean a supplier's certificate is sufficient?

It means identification should be present and its absence is hard to excuse. Whether a certificate is sufficient depends on what else it contains, which is covered separately in this category.

KLOW (Blend)

One Thing This Blend Makes Easy

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-244 cited sources

The four components of KLOW have molecular weights of 342.43, 402.92, 889.0 and 1419.5 daltons. The gaps between them are far larger than the resolution of any mass spectrometer, so identifying all four in one sample is an easy analytical problem.

Key facts

Smallest gap between components: 60.49 Da, between KPV and GHK-Cu
Largest component: BPC-157, 1419.5 Da
Smallest component: KPV, 342.43 Da
Isobaric overlap: None
Typical instrument resolution: Far finer than 60 Da
Distinguishing feature of GHK-Cu: Copper isotope pattern
What this makes easy: Confirming all four are present
What it does not make easy: Determining how much of each

A rare piece of good news about a blend

Most of what can be said about a four-component mixture concerns what it makes harder. This is the exception. The four components here happen to have molecular weights that are widely and unevenly spaced - 342.43, 402.92, 889.0 and 1419.5 daltons - and the smallest gap between any two is just over sixty daltons. Mass spectrometers routinely resolve differences of a fraction of a dalton. Confirming that four peaks are present at four expected masses in a single injection is therefore a straightforward measurement, not a difficult one.

What isobaric overlap would look like, and why it does not arise here

The analytical nightmare in mixture work is two components with the same or nearly the same mass. Peptides make this easy to stumble into: leucine and isoleucine are identical in mass, and several combinations of residues sum to the same total, so two unrelated sequences can be indistinguishable by mass alone and require fragmentation or chromatographic separation to tell apart. None of that applies here. No two of these four are within an order of magnitude of instrument resolution of each other, and no plausible adduct or charge state of one lands on the expected mass of another.

Research material referenced

KLOW 80mg — third-party HPLC tested

View — £69.99

The copper gives a second, independent confirmation

GHK-Cu carries a chelated copper ion, and copper has two stable isotopes in a well-known ratio. That produces a characteristic isotope pattern around the molecular ion which is not something a copper-free peptide can imitate. So the component most likely to be substituted or misrepresented - the one whose identity depends on a metal being present and correctly bound - is also the one that carries its own independent signature. A spectrum showing the right mass without the right isotope envelope is telling you something specific has gone wrong.

What easy identification does not buy

Quantification. Confirming four peaks are present says the four components are there; it does not say in what proportions. Peptides ionise with wildly different efficiencies depending on their charge, sequence and the conditions used, so relative peak heights in a mass spectrum are not relative abundances. Turning a spectrum into a per-component mass requires calibration against a reference standard for each component, run under the same conditions. That is entirely doable and it is a different, more laborious measurement than the identity check.

How to use this when reading a certificate

A certificate for a blend should show that each component was identified, and given how easy identification is here, its absence for any component is a meaningful omission rather than a technical limitation. Per-component purity figures indicate each material was tested to specification before combining. The figure that would settle the most - how many milligrams of each are in the vial - is a quantitative result and is the one usually missing, which is worth distinguishing from the identity data that is usually present.

The general lesson

Analytical difficulty in a mixture is a property of the specific components, not of mixtures in general. This particular set of four is unusually well-behaved: no isobaric collisions, a wide mass spread, and one component carrying a metal isotope signature. A different four-component blend with two similarly sized peptides would be a materially harder problem. That is a reason to check the actual masses before assuming either that a blend is easy to verify or that it is impossible. These are supplied for laboratory research only.

Quick reference

Component	MW (Da)	Gap to next	Independent confirmation available
KPV	342.43	60.49	None beyond mass
GHK-Cu	402.92	486.08	Copper isotope pattern
TB-500	889.0	530.5	None beyond mass
BPC-157	1419.5	-	None beyond mass

Extended research context

The KLOW (Blend) deep dive

Deep dive: a fourfold size range in one cake, and what partial dissolution hides

KLOW's components run from KPV at 342.43 daltons to BPC-157 at 1419.5 - a fourfold span, and the widest of any product in this catalogue. Solubility depends on size, charge distribution and hydrophobicity, and these four differ in all three, so a co-lyophilised cake containing all of them releases its components in sequence rather than together. The hazard follows directly and is easy to miss: a cake that looks partly dissolved is not uniformly partly dissolved. The smallest component may be entirely in solution while the largest has barely started. Draw from the vial at that moment and the sample is enriched in the fast components and depleted in the slow ones - a composition error with no visible sign at all, since the liquid looks like liquid. The instinctive response to visible solid makes it worse: shaking creates air-liquid interfaces, which is exactly where peptides unfold and then aggregate irreversibly. The correct response is diluent down the vial wall, gentle swirling, and more patience than a single peptide or even a three-component blend requires. There is a second asymmetry on top. Small peptides adsorb to glass and plastic more readily than large ones, so KPV is the component most likely to be lost to container walls at low concentration - a silent shift in the effective ratio that no certificate figure accounts for.

Deep dive: the cleanest possible comparison, which still cannot be run

KLOW is a strict superset of GLOW - the same three components plus KPV, at 80 mg against 70 mg. Product comparisons rarely have this structure. There is nothing in GLOW that KLOW lacks, so the difference between them reduces to a single question rather than a balance of trade-offs, and in principle comparing the two would isolate exactly what KPV contributes. In practice it cannot be done. The 10 mg difference in total might be 10 mg of added KPV with the other three unchanged, or it might be a redistribution across all four; both are consistent with the published figures, and neither product states its split. So any difference observed between the two could be KPV, or it could be a changed concentration of GHK-Cu, BPC-157 or TB-500. The experiment that the product pairing seems designed to permit is precisely the one the missing information forbids. This is the fixed-ratio limitation in its sharpest form: not that the format is unhelpful in general, but that it withholds the one number that would make the most natural question answerable.

Deep dive: two products from one hormone, in categories that never mention each other

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, isolated because that hormone does two functionally separable things - pigmentation through melanocortin receptors, and anti-inflammatory activity localised to its C-terminal end. KPV keeps the second and discards the first. Now look elsewhere in this catalogue: MT-2 is also an alpha-MSH derivative, and it is built around the melanocortin-receptor-binding core that KPV was specifically designed to leave behind. Two products, one parent hormone, opposite halves of its function, sitting in entirely separate product categories with nothing in either listing to indicate they are related. The size difference tracks the design logic. KPV at 342.43 daltons is three residues with no modifications, because an effect running through diffuse intracellular signalling can survive extreme truncation. MT-2 at 1024.2 daltons is seven residues plus a lactam bridge, a D-amino acid and two capped termini, because receptor engagement requires enough structure to present a specific surface. What a fragment needs to be depends entirely on what the retained function requires, and these two are as clean an illustration of that as this catalogue contains.

Research applications

▸Multi-component connective tissue research protocols
▸Comparative work on three-component versus four-component combinations
▸Co-lyophilisation and multi-component dissolution methodology
▸Copper peptide compatibility studies
▸Surface adsorption behaviour across a wide molecular size range
▸Anti-inflammatory and matrix pathway research

Handling checklist

✓Verify KPV as Lys-Pro-Val at 342.43 Da, CID 125672 - never by searching 'KPV'
✓Verify GHK-Cu against 402.92 Da (CID 71587328), not 340.38 for free GHK
✓Verify TB-500 against 889.0 Da, not 4.9 kDa for thymosin beta-4
✓Verify BPC-157 against 1419.5 Da
✓Expect four separate certifications - a single combined purity figure is a category error
✓Allow more dissolution time than a three-component blend; do not draw before it completes
✓Use low-binding consumables - KPV is the component most lost to surfaces
✓Store lyophilised, cold, dry and dark; the copper complex governs light protection

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Drawing from a partly dissolved four-component cake

Fix: Components dissolve in sequence across a fourfold size range. An early sample is enriched in fast components and depleted in slow ones, with no visible sign.

✗ Verifying the KPV component by searching 'KPV' in PubChem

Fix: That returns 2-oxo-5-phenylpentanoic acid at 192.21 Da, an unrelated compound. Search Lys-Pro-Val for CID 125672.

✗ Assuming the 10mg difference from GLOW is 10mg of KPV

Fix: Not stated. It could be added KPV with the others unchanged, or a redistribution across all four.

✗ Treating four component literatures as evidence about the blend

Fix: No published work addresses this combination or any subset of it. Summing separate literatures produces no evidence about a mixture.

✗ Adding a chelator because the blend contains copper

Fix: Unnecessary. None of the four components contains cysteine or methionine, so copper-catalysed oxidation has no substrate here.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Does this mean a mass spectrum proves the blend is correct?: It proves four species of the expected masses are present. It does not establish their proportions, their purity, or that the material is what the label says in every respect - a correct mass is consistent with the right compound and does not by itself exclude an isomer.
Why can leucine and isoleucine not be told apart by mass?: They have identical elemental composition and therefore identical mass. Distinguishing them requires fragmentation patterns or chromatographic behaviour, which is a standard problem in peptide analysis and simply does not arise between these four components.
Is the copper isotope pattern hard to see?: No - it is one of the more recognisable signatures in small-molecule mass spectrometry, because the two stable isotopes are separated by two mass units in a consistent ratio. Its absence where copper is claimed is straightforward to notice.
Does easy identification mean a supplier's certificate is sufficient?: It means identification should be present and its absence is hard to excuse. Whether a certificate is sufficient depends on what else it contains, which is covered separately in this category.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More KLOW (Blend) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum